The American pharmaceutical company has become the largest supplier of vaccines in Europe
Coronavirus in Catalonia: check the vaccination calendar against the pandemic
A woman receives the Pfizer vaccine at the Sant Pau Hospital in Barcelona in January.
The European Union has reserved an additional 100 million doses of the Pfizer vaccine, which are expected to arrive before the end of the year and bring the doses purchased from its developers to 600 million, according to the European Commissioner for Health, Stella Kyriakides.
Following the announcement by the Spanish Minister Carolina Darias about the arrival of 1.7 million weekly doses of Pfizer from May to Spain, the European Union confirms through Commissioner Kyriakides’s Twitter the purchase of these 100 million extra doses , for which he has assured that “we continue working tirelessly so that vaccines reach the citizens quickly”.
Pfizer, “the column” of European vaccination
Specifically, these doses were contemplated in the second contract concluded between the community authorities and the two Pfizer developer laboratories, which consisted of the direct acquisition of 200 million doses and the possibility of buying another 100 million more.
The European Commission has also stated that it considers the pharmaceutical company Pfizer and its doses against the coronavirus “the backbone” of vaccination in Europe, as it has become the main supplier to the EU.
However, as confirmed this Thursday at a press conference by the chief spokesman for the European Commission, Eric Mamer, the Executive has not renounced other drugs such as Janssen or AstraZeneca.
A woman over 80 years old receives the Pfizer vaccine against covid in Barcelona.
Fighting the pandemic
This is how the covid vaccination progresses in Catalonia: data and last minute
Key months for immunization
European countries expect to receive some 250 million doses of Pfizer between April and June, three key months to accelerate herd immunization.
Albert Bourla, president of Pfizer, has assured that the pharmaceutical company is committed to getting its vaccine “as quickly as possible.” For his part, Sean Marett, BioNTech’s business manager and commercial director, stressed that this new batch of additional doses “will help drive the acceleration of vaccination campaigns throughout the EU.”
A Spanish clinical trial will study the mixed vaccination of AstraZeneca and Pfizer in children under 60
Health proposes to delay the second doses of Pfizer and Moderna to vaccinate more
At the moment, the latest data from the Ministry of Health shows that 19% of the Spanish population – just over 9 million people – have received at least one dose of the vaccines. 7% of Spaniards have already received both doses.
Of the 13,703,085 doses delivered in Spain, 90% have already been administered.